Financials

  • Market Capitalization 217.49 M
  • Employee 95
  • Founded N/A
  • CEO Daniel Vitt
  • Website www.imux.com
  • Headquarter Delaware, United States
  • FIGI BBG001M75SX4
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-0.86
ratio cours/chiffre d'affaires
-167.18

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
3554
CHRS
Coherus Oncology, Inc. - Common Stock
1.45 USD-0.68%+3.57%+0.69%-9.94%224.03 M USD
3564
KROS
Keros Therapeutics, Inc. - common stock
11.23 USD+0.99%+3.31%+10.75%-25.63%222.66 M USD
3572
ABOS
Acumen Pharmaceuticals, Inc. - Common Stock
3.01 USD-0.66%-6.81%+31.44%+122.96%217.68 M USD
3573
BCYC
Bicycle Therapeutics plc - American Depositary Shares
4.33 USD-0.69%-1.37%+10.18%-39.36%218.90 M USD

Nouvelles